News

Federal plan emphasizes heroin/opioid treatment over incarceration


 

References

WASHINGTON – The Obama administration announced Aug. 17 that it will spend an additional $13.4 million fighting opioid and heroin abuse, emphasizing treatment over law enforcement.

The increased emphasis will center on geographic areas where heroin and opioid abuse are rampant, specifically Appalachia; New England; Philadelphia/Camden, N.J.; metropolitan New York City, particularly northern New Jersey; and the Washington/Baltimore metro region. Public safety officers and first responders will be trained in how to administer naloxone and provide other medical attention for those in the midst of a heroin or opioid overdose.

heroin ©PaulPaladin/thinkstockphotos.com

The 15 states in the targeted areas will share and leverage data to determine regional patterns of heroin and prescription painkiller-related overdose. These data are expected to delineate where the narcotics – especially those laced with other, more dangerous drugs – are being produced and distributed so that heroin response teams can disrupt the production and distribution of illegal drugs, but respond pre-emptively by expanding resources to communities hardest hit.

In a statement, Michael Botticelli, director of the White House Office of National Drug Control Policy, said the administration’s emphasis on “the national drug challenge as both a public health and public safety issue” is based on viewing drug addiction as “a chronic disease of the brain that can be successfully prevented and treated, and from which one can recover.”

The initiative also will provide additional funding for similar efforts to address opioid abuse and methamphetamine abuse in the Southwest and along the United States/Mexico border.

“This program demonstrates the importance of linking health to criminal justice in collaboration rather than seeing better, new drug policy as a choice between health and law enforcement,” Dr. Robert L. DuPont, former director of the National Institute on Drug Abuse (NIDA), and president of the Institute for Behavior and Health, said in an interview.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

PCPC: Avoid these traps when prescribing medical marijuana
MDedge Internal Medicine
VIDEO: Tailor chronic pain interventions to patient’s clinical profile
MDedge Internal Medicine
IHC: Botox for migraine also improves depression
MDedge Internal Medicine
Disability with chronic widespread pain linked to alcohol consumption
MDedge Internal Medicine
Optimized analgesia, exercise cut pain in severe knee OA
MDedge Internal Medicine
PCPC: Get patients to unlearn cognitive distortions that sustain pain
MDedge Internal Medicine
Unvetted drug indications mean safety uncertainties
MDedge Internal Medicine
VIDEO: Primary care is pain care’s front line
MDedge Internal Medicine
Nocturnal back pain suggests systemic disorder
MDedge Internal Medicine
New shingles vaccine delivers whopping efficacy
MDedge Internal Medicine